Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?
Intensive Care Med
.
2020 Oct;46(10):1897-1900.
doi: 10.1007/s00134-020-06170-8.
Epub 2020 Jul 17.
Authors
A Guillon
1
2
3
,
P S Hiemstra
4
,
M Si-Tahar
5
6
Affiliations
1
Intensive Care Unit, Tours University Hospital, 2 Bd Tonnellé, 37044, Tours Cedex 9, France. antoine.guillon@univ-tours.fr.
2
University of Tours, Tours, France. antoine.guillon@univ-tours.fr.
3
Research Center for Respiratory Diseases, INSERM U1100, Tours, France. antoine.guillon@univ-tours.fr.
4
Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands.
5
University of Tours, Tours, France.
6
Research Center for Respiratory Diseases, INSERM U1100, Tours, France.
PMID:
32681297
PMCID:
PMC7366461
DOI:
10.1007/s00134-020-06170-8
No abstract available
Publication types
Comment
MeSH terms
Betacoronavirus
COVID-19
Coronavirus Infections*
Humans
Immune Evasion
Pandemics*
Pneumonia, Viral*
RNA
SARS-CoV-2
Severe Acute Respiratory Syndrome*
Substances
RNA